12 reports

Global Orphan Diseases Partnering 2010 to 2021 provides the full collection of Orphan Diseases disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Orphan Diseases partnering deals Financial deal terms for headline, upfront and royalty by stage of development Orphan...

  • Orphan Disease
  • World

Peptides to Inhibit CXCR## for Melanoma and Orphan Diseases – Drug Profile

  • Therapy
  • Lymphoma
  • Gene Therapy
  • Orphan Disease
  • World
  • Health Provider Density

Peptides to Inhibit CXCR## for Melanoma and Orphan Diseases – Drug Profile

  • Therapy
  • Lymphoma
  • Orphan Disease
  • Gene Therapy
  • World
  • Drug Approval

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....

  • Orphan Disease
  • Packaging
  • World

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....

  • Injectable Delivery
  • Neurology
  • Orphan Disease
  • Home Healthcare
  • Analgesic
  • Packaging
  • World

This study covers the world outlook for neurometabolic disorder treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Spacecraft
  • Satellite Launch
  • Mouth Disease
  • Orphan Disease
  • Beef
  • Packaging
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for self-injections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Spacecraft
  • Satellite Launch
  • Injectable Delivery
  • Neurology
  • Mouth Disease
  • Orphan Disease
  • Beef
  • Home Healthcare
  • Analgesic
  • Packaging
  • World
  • Gross Domestic Product
  • Disposable Income

Summary Mast Therapeutics Inc (Mast Therapeutics) is a biopharmaceutical company, which develops clinical-stage therapies for serious or life-threatening diseases. The company develops therapies for sickle cell disease, a chronic, genetic disorder for rare or orphan disease. The company’s lead product MST-188 (also known as...

  • Pharmaceutical
  • Blood Disease
  • Therapy
  • Biopharmaceutical
  • Genetic Disorder
  • Heart Failure
  • Orphan Disease
  • Hospital
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • San Diego County
  • Central America

Summary Stichting Lygature(Lygature), formerly Top Institute Pharma (TI pharma) is a not-for-profit organization. It focuses on the development of solutions for medical technology and pharmacotherapy in public-private partnership with academia, industry and society. The organization expertise spans in the areas of resource sharing,...

  • Pharmaceutical
  • Healthcare
  • Healthcare IT
  • Orphan Disease
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • Utrecht

Summary Raptor Pharmaceutical Corp (Raptor) is a biopharmaceutical company that develops and commercializes therapeutics for orphan diseases. The company’s lead product, Procysbi is a cysteamine bitartrate delayed-release capsule and is used in the treatment of a rare genetic disorder, nephropathic cystinosis. Its second product,...

  • Pharmaceutical
  • Therapy
  • Biopharmaceutical
  • Healthcare
  • Genetic Disorder
  • Cystic Fibrosis
  • Orphan Disease
  • Digestive System Disorder
  • Liver Cancer
  • APAC
  • North America
  • California
  • Europe
  • Middle East
  • Africa

Summary Hyperion Therapeutics Inc (Hyperion) is a biopharmaceutical company. It develops and commercializes novel drugs for the treatment of orphan diseases and hepatology disorders. Ravicti, the company’s first approved product is indicated for use as a nitrogen-binding agent in adult and pediatric patients aged above two years...

  • Pharmaceutical
  • Biopharmaceutical
  • Healthcare
  • Health Insurance
  • Orphan Disease
  • APAC
  • California
  • North America
  • Europe
  • San Mateo County
  • Middle East
  • Africa

This report presents quick facts about Medgenics, Inc., which is principally involved in Developing Medicines for Treating Clinical Stage Rare and Orphan Diseases. Illustrated with 13 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Orphan Disease
  • United States